ArticleAnnals of hematology2020

Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.

Olga Mulas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.